Mohsen Sharifzadeh

Dr. Mohsen Sharifzadeh

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
IEIgor V. Ermakov
Igor V. Ermakov
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
MEMaia R. Ermakova
Maia R. Ermakova
WGWerner Gellermann
Werner Gellermann
Raman spectroscopy is a highly specific form of vibrational spectroscopy that has long been routinely used to identify and quantify chemical compounds. Carotenoid molecules are especially suitable for Raman measurements since they can be excited with light overlapping their visible absorption bands. Under this excitation condition, they exhibit a very strong resonance Raman scattering (RRS) response, with an enhancement factor of about five orders of magnitude relative to nonresonant Raman spectroscopy.1 This enables one to detect the characteristic vibrational energy levels of carotenoids through their corresponding spectral fingerprint signature even in complex biological systems, as in living human tissue. Any off-resonance Raman response from other molecules present in the sampling volume would be strongly suppressed under these conditions and would be buried in background noise. Also, the tissue environment of the carotenoids has only a negligible effect on the vibrational energy, thus making the Raman signature virtually identical for the isolated carotenoid molecule, the molecule in solution, or the molecule in a cell environment.

14 May 2009 in Biochemistry
Verified
Journal Article
Closed access
PBPrakash Bhosale
Prakash Bhosale
BLBinxing Li
Binxing Li
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
WGWerner Gellermann
Werner Gellermann
JFJeanne M. Frederick
Jeanne M. Frederick
PBPaul Bernstein
Paul Bernstein

1 August 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
BHBradley S. Henriksen
Bradley S. Henriksen
GCGary Chan
Gary Chan
RHRobert O. Hoffman
Robert O. Hoffman
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
IEIgor V. Ermakov
Igor V. Ermakov
PBPaul Bernstein
Paul Bernstein
Purpose.: Deposition of the macular pigment carotenoids lutein and zeaxanthin in the human retina occurs early in life. In this study, we examined the interrelationships of maternal carotenoid status and newborn infant macular pigment levels and systemic carotenoid status. As a secondary measure, we also evaluated the effects of intrauterine growth restriction (IUGR) on carotenoid status in term newborn infants. Methods.: We measured mother and infant skin carotenoids using resonance Raman spectroscopy (RRS), serum carotenoids by HPLC, and mother breast milk carotenoids by HPLC. We measured infant macular pigment levels using noninvasive blue light reflectometry. Results.: We enrolled 30 healthy term infants, their mothers, and 10 IUGR infants and their mothers. A subset of 16 infants was imaged for macular pigment optical density (MPOD). Infant serum zeaxanthin levels correlated with MPOD (r = 0.68, P = 0.007). Mother serum zeaxanthin levels correlated with infant MPOD (r = 0.59, P = 0.032). Infant and mother serum lutein did not correlate with MPOD. Mother–infant correlations were found for total serum carotenoids (r = 0.42, P = 0.020) and skin carotenoids (r = 0.48, P = 0.001). No difference was seen between IUGR infants and controls in total serum or skin carotenoids. Mothers of IUGR infants had lower total serum carotenoids (P = 0.019) and breast milk carotenoids than controls (P = 0.006). Conclusions.: Our findings suggest that maternal zeaxanthin status may play a more important role than lutein status in macular pigment deposition in utero. Controlled trials are needed to determine whether maternal zeaxanthin prenatal supplementation can raise infant macular pigment levels and/or improve ocular function.

25 March 2008 in Journal of the Optical Society of America A
Verified
Journal Article
Closed access
PDF file
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
DZDa-You Zhao
Da-You Zhao
PBPaul S. Bernstein
Paul S. Bernstein
WGWerner Gellermann
Werner Gellermann
We describe resonance Raman imaging (RRI) of macular pigment (MP) distributions in the living human eye. MP consists of the antioxidant carotenoid compounds lutein and zeaxanthin, is typically present in high concentrations in the healthy human macula relative to the peripheral retina, and is thought to protect this important central region from age-related macular degeneration. We demonstrate that RRI is capable of quantifying and imaging the spatially strongly varying MP distribution in the human retina. Using laser excitation of the MP molecules at 488nm, and sequential camera detection of light emitted back from the retina at the MP’s strongest Raman peak position and at an off-peak position, RRI maps of MP are obtained at a resolution below 50μm within a fraction of a second per exposure. RRI imaging can be carried out with undilated pupils and provides a highly molecule-specific diagnostic imaging approach for MP distributions in human subjects.

1 June 2018 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
Akira ObanaAkira Obana
Akira Obana
YGYuko Gohto
Yuko Gohto
HSHiroyuki Sasano
Hiroyuki Sasano
WGWerner Gellermann
Werner Gellermann
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
PBPaul S. Bernstein
Paul S. Bernstein
Purpose: To evaluate the influence of cataracts on measuring macular pigment optical density (MPOD) using a dual-wavelength confocal scanning autofluorescence imaging technique and to establish methods to compensate for the influence of cataracts. Methods: This prospective case series comprised 100 eyes that underwent cataract surgery. Cataracts were graded based on the World Health Organization classification. MPOD levels were measured with the MPOD module of the Spectralis MultiColor instrument (Spectralis-MP), pre- and postoperatively. We investigated the relationship between change in MPOD values and age, cataract grade, and quality of autofluorescence images. Local MPOD levels were evaluated for four strategically chosen eccentricities within the macular region, and the total MPOD volume was evaluated within 8.98° eccentricity from the center. Results: MPOD levels could be obtained in 67 eyes before surgery. Local and volume MPOD levels were higher postoperatively relative to preoperatively in all eyes. The mean ratio of local MPOD levels after and before surgery (correction factor, CF) ranged from 1.42 to 1.77, with larger CFs required for eccentricities closer to the foveal center. The CF for the MPOD volume was 1.31. Age, grade of nuclear cataract (NUC), posterior subcapsular opacity, and image quality index (IQI) significantly contributed to CFs. For example, regression equation for CF at 0.23° = 0.17 + 0.16 × IQI + 0.29 × NUC grade + 0.01 × age (P < 0.001). Conclusions: Cataracts affected MPOD measurements with the Spectralis-MP, but corrected MPOD results could be obtained via regression equations.

24 April 2024 in Ophthalmology Science
Verified
Journal Article
Open access
EAEmmanuel K. Addo
Emmanuel K. Addo
JGJoanna E. Gorka
Joanna E. Gorka
SASusan J. Allman
Susan J. Allman
DHDeborah Y. Harrison
Deborah Y. Harrison
MSMohsen Sharifzadeh
Mohsen Sharifzadeh
PBPaul Bernstein
Paul Bernstein
Lutein (L) and zeaxanthin (Z) are xanthophyll carotenoids that have been promoted to enhance maternal health and infant visual and neurodevelopment. In this study, we determined the effects of prenatal L and Z supplementation on systemic and ocular carotenoid status in the mother and her newborn infant (NCT03750968). This report focuses on the ocular effects of prenatal carotenoid supplementation. A prospective randomized clinical trial with 47 subjects randomly assigned by 1:1 allocation to receive standard-of-care prenatal vitamins along with 10 mg L and 2 mg Z softgel (Carotenoid Group) or standard-of-care prenatal vitamins with a placebo softgel (Control Group) starting in the first trimester. We enrolled low-risk pregnancy subjects aged ≥18 years from the obstetrics and gynecology clinic of the University of Utah Hospital. Maternal macular, skin, and serum carotenoid concentrations were measured using autofluorescence imaging, resonance Raman spectroscopy, and high-performance liquid chromatography, respectively. Infants’ ocular carotenoids and retinal architecture were measured by blue light reflectance imaging and spectral-domain OCT, respectively. Changes in maternal and infant macular pigment, skin, and serum carotenoid status over the study period. Differences in infants’ retinal maturity indicators between the 2 study groups. Following supplementation, there was a statistically significant increase in maternal macular pigment optical volume (P < 0.001) in the Carotenoid Group relative to the Control Group at all study time points, and there was no detectable maternal ocular carotenoid depletion. Infant skin and serum carotenoids increased significantly in the Carotenoid Group compared with the Control Group. As exploratory endpoints, infants in the Carotenoid Group had a 20% increase in macular pigment optical density (P = 0.242) and more mature foveal parameters compared with those in the Control Group. Prenatal carotenoid supplementation significantly increased maternal and infant systemic carotenoids and caused a pattern of increased infant ocular carotenoid status, which may benefit both mothers and their infants’ ocular development and function. This study provides important data to design and power a future multicenter study of prenatal carotenoid supplementation in higher-risk pregnancies. The author(s) have no proprietary or commercial interest in any materials discussed in this article.